Virax Biolabs Group Ltd Proceeds From Exercise Of Warrants
Virax Biolabs Group Ltd (VRAX) reported Proceeds From Exercise Of Warrants of $786.74 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2025-07-02
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2025-03-31 | $786.74K 20-F · filed 2025-07-02 |
| 2024-03-31 | $1.87M 20-F · filed 2025-07-02 |